Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
07/2007
07/26/2007US20070173509 Imidazole compounds
07/26/2007US20070173507 Dairyl-substituted five-membered heterocycle derivative
07/26/2007US20070173501 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
07/26/2007US20070173486 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent; antidepressant; eating disorders, obesity, nicotine addiction, neuropathy, cognitive disorders, attention deficit disorder, stress, epilepsy, dementia, distonia, Alzheimer's
07/26/2007US20070172951 Time-temperature indicator based on valence isomerizations
07/26/2007US20070172421 Substituted pyrrolidine-2-ones
07/26/2007CA2637565A1 Cannibinoid receptor modulators
07/26/2007CA2637057A1 Diaryl piperidines as cb1 modulators
07/26/2007CA2636916A1 Methods for treating hepatitis c
07/26/2007CA2636905A1 Methods for treating hepatitis c
07/26/2007CA2636824A1 Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors
07/26/2007CA2633100A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
07/26/2007CA2631876A1 Aminophenyl derivatives as inhibitors of histone deacetylase
07/26/2007CA2631874A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
07/26/2007CA2630717A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
07/25/2007EP1809619A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
07/25/2007EP1809606A1 Compounds having activity at nk3 receptor and uses thereof in medicine
07/25/2007EP1809290A2 Pyrimidine derivatives as ion channel modulators and methods of use
07/25/2007EP1658272B1 Novel gamma-secretase inhibitors
07/25/2007EP1581207A4 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
07/25/2007EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2007EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands
07/25/2007CN101006082A Histamine H3 receptor agents, preparation and therapeutic uses
07/25/2007CN101006078A Gonadotropin releasing hormone receptor antagonists
07/25/2007CN101006076A Modulators of ATP-binding cassette transporters
07/25/2007CN101006058A Chemical compounds I
07/25/2007CN101006055A 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase iepsilon
07/24/2007US7247735 Having a benzene ring 1,3,5-trisubstituted with 2-6 conjugated thiophene, furan or pyrrole rings, e.g., 1,3,5-Tris[-(5'''-ethyl)-2,2':5',2'':5'',2'''-quartthiophenyl]benzene
07/24/2007US7247734 In which the 3-phenyl group is 2,4-dihydroxy-substituted, e.g., 4-[5-bromo-4-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-6-chloro-benzene-1,3-diol; heat shock protein 90 inhibitors
07/24/2007US7247726 Generating chemiluminescence by reaction with peroxidase compound and detection of signal with analyzing compound
07/24/2007US7247635 Pyrazole derivative
07/24/2007US7247633 Pyrimidine compounds and their use
07/24/2007US7247628 Cannabinoid receptor ligands and uses thereof
07/24/2007CA2238274C Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
07/24/2007CA2192480C Benzopyrans and their use as therapeutic agents
07/19/2007WO2007082262A2 Novel compounds
07/19/2007WO2007080947A1 Diketooxime ester compound and use thereof
07/19/2007WO2007080720A1 Pyridazine compound and use thereof
07/19/2007WO2007080401A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents
07/19/2007WO2007080382A1 Morpholino pyrimidine derivatives and their use in therapy
07/19/2007WO2007054453A3 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa
07/19/2007US20070167655 Method for the production of tetrahydrogeranylacetone
07/19/2007US20070167514 Cannabinoid derivatives, methods of making, and use thereof
07/19/2007US20070167507 4-Carbox pyrazole derivatives useful as anti-viral agents
07/19/2007US20070167499 Biaryl linked hydroxamates: preparation and pharmaceutical applications
07/19/2007US20070167498 Carboxylic acid compounds
07/19/2007US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof
07/19/2007US20070167491 N-[2-(5-chloro-2-pyridinyl)propyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, used for the control of phytopathogenic fungi of plants; pesticides
07/19/2007US20070167490 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
07/19/2007US20070167486 such as 3-[1-(2,4-Dimethoxybenzyl)-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-hydroxypropionamide, used for preventing and treating the inflammatory diseases, for example rheumatoid arthritis, gout, osteoarthritis, lupus, arthritis, Crohn's disease, diabetes, bursitis, burns and scaring
07/19/2007US20070167483 Phenylalanine Enamide Derivatives
07/19/2007US20070167449 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors
07/19/2007US20070167448 Derivatives of sulphonamides, their preparation and use as medicaments
07/19/2007US20070167447 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
07/19/2007US20070167444 Benzamide derivative or salt thereof
07/19/2007US20070167441 Xanthones, thioxanthones and acridinones as dna-pk inhibitors
07/19/2007US20070167440 Novel pyrrolidine compound and a process for preparing the same
07/19/2007US20070167437 Antiproliferative agents; anticarcinogenic agents; cis-[4,5-Bis-(4-chloro-phenyl)-2-(4-ethoxy-2-trifluoromethyl-pyrimidin-5-yl)-4,5-dihydro-imidazol-1-yl]-[4-(2-methanesulfonyl-ethyl)-piperazin-1-yl]-methanone; inhibitors of the MDM2-p53 interaction
07/19/2007US20070167423 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent
07/19/2007US20070167421 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
07/19/2007DE112005002083T5 Lichtemittierende Polymerzusammensetzung und polymere lichtemittierende Vorrichtung The light emitting polymer composition and polymer light emitting device
07/19/2007CA2635997A1 Morpholino pyrimidine derivatives and their use in therapy
07/19/2007CA2635916A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents
07/19/2007CA2635827A1 Anthranilamide derivatives and their use for the control of insects and acari
07/18/2007EP1807420A1 Trisubstituted thiophenes as progesterone receptor modulators
07/18/2007EP1807419A1 (2-carboxamido)(3-amino) thiophene compounds
07/18/2007EP1807412A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors
07/18/2007EP1807407A1 Aromatic amides as inhibitors of c-fms kinase
07/18/2007EP1807406A2 Inhibitors of c-fms kinase
07/18/2007EP1807405A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
07/18/2007EP1807392A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor
07/18/2007EP1807082A2 Factor xa compounds
07/18/2007EP1807078A1 Diaminoalkane aspartic protease inhibitors
07/18/2007EP1807072A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
07/18/2007EP1711184B1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
07/18/2007EP1565436A4 3-aminopyrrolidine derivatives as modulators of chemokine receptors
07/18/2007EP1403250B1 Bis(5-aryl-2-pyridyl) derivative
07/18/2007EP1123291B1 Process for preparing 3-(substituted phenyl)-5-thienyl or furyl)-1,2,4-triazoles and novel intermediates utilized therein
07/18/2007CN1326854C Substituted derivatives of aminofuran-2-Y1-acetic acid and aminothien-2-Y1-acetic acid and use thereof for treating migraines and pain
07/18/2007CN1326848C Aminopyrazole derivatives
07/18/2007CN1326841C Arylalkane-sulfonamides having endothelin-antagonist activity
07/18/2007CN1326838C Benzo[d]azepine derivatives for the treatment of neurological disorders
07/18/2007CN101001845A Substituted quinazolones as anti-cancer agents.
07/18/2007CN101001626A Pyrazole derivatives for treating conditions mediated by activation of the adenosine A2b or A3 receptor
07/17/2007US7244847 Bactericides
07/17/2007US7244846 Substituted benzofuran-2-carboxamides derivatives
07/17/2007US7244745 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
07/17/2007US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy
07/17/2007US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone
07/12/2007WO2007079470A2 Therapeutic amine-arylsulfonamide conjugate compounds
07/12/2007WO2007079199A2 Substituted bis-amide metalloprotease inhibitors
07/12/2007WO2007077508A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
07/12/2007WO2007077247A1 Piperazine compounds with a herbicidal action
07/12/2007WO2007077201A1 Piperazine compounds with a herbicidal action
07/12/2007WO2007077005A1 3 , 5-substitγued piperidine compounds as renin inhibitors
07/12/2007WO2007061948A3 Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
07/12/2007WO2007042321A3 Kinase inhibitors
07/12/2007WO2007034279A3 C3a antagonists and pharmaceutical compositions thereof
07/12/2007US20070161787 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
07/12/2007US20070161701 4-oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof